BIOTIE THERAPIES CORP. Stock Exchange Release 20 January 2015 at 9.00am Change in the number of votes relating to Biotie Therapies Corp.'s shares Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares, that were issued on 17 December 2014, pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans"), as follows: Shares conveyed Cumulative shares conveyed Remaining shares to be since 17 December 2014 conveyed 1,009,375 1,009,375 1,438,000 Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company, of which a total of 1,844,250 were subscribed for in 2014. A total of 942,500 shares have been subscribed for during the period 17 December 2014 and 19 January 2015 and 942,500 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 9,425 funds received will be credited to the Company's reserve for non-restricted equity. Due to share issues already made pursuant to the Stock Option Plan 2011, forfeitures and some of the instruments based on the plan having been left unallocated, a maximum of 3,080,500 shares may still be issued pursuant to the Stock Option Plan 2011. The second vesting period of the Equity Incentive Plan 2011 ended on 5 January 2015, after which the Company's shares shall be delivered to employees on the basis of the granted share units. It was resolved pursuant to the authorization of the Annual General Meeting of the Shareholders held on 3 April 2014 to issue 66,875 existing treasury shares to the employees without consideration for the purposes of remunerating the employees pursuant to the terms and conditions of the Equity Incentive Plan 2011 and thus, there is an especially weighty financial reason to derogate from the pre-emptive right of the shareholders, as referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as amended). Due to share issues already made pursuant to the Equity Incentive Plan 2011, forfeitures and some of the instruments based on the plan having been left unallocated, a maximum of 1,382,500 shares may still be issued pursuant to the Equity Incentive Plan 2011. The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows: Increase in number of Total amount of Number of the Total number outstanding shares voting rights Company's shares held of registered by the Group shares 1,009,375 451,705,390 4,262,784 455,968,174 Turku, 20 January 2015 Biotie Therapies Corp. Timo Veromaa, President and CEO For further information, please contact: Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp. tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com www.biotie.com DISTRIBUTION: NASDAQ OMX Helsinki Ltd Main Media [HUG#1888220]
Change in the number of votes relating to Biotie Therapies
Top 10 Most Recent News Articles
CSTS Unveils PremierX in NYC: A Bold Entertainment Move
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Darden Faces Class Action Over Reimbursement Failures
Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...
Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians
Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
What to Expect: Your First Therapy Session Insights
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue ReadingTop 5 Most Recently Viewed Articles
Bull Market Optimism Fueled by AI Growth After TSMC Results
Insights on AI Market Dynamics and TSMC's Performance In a recent discussion, Gene Munster provided his perspective on the burgeoning AI market landscape, particularly highlighting the recent performance of Taiwan Semiconductor Manufacturing Company Ltd (NASDAQ: TSM). After TSMC reported promising third-quarter results, Munster emphasized the need for investors to...
Continue Reading
Understanding Mueller Industries Inc's Earnings Performance
Current Market Performance of Mueller Industries Inc Mueller Industries Inc. (NYSE: MLI) is currently trading at $81.46, marking a slight increase of 0.74% in its latest session. This upward trajectory indicates a positive trend as the stock saw an increase of 0.73% in the past month and an impressive 57.50% in the past year. These figures present a favorable outlook for...
Continue Reading
RayNeo and Bang & Olufsen Join Forces for New Audio Experience
RayNeo Partners with Bang & Olufsen for Enhanced AR Experience RayNeo, a recognized leader in augmented reality eyewear, has taken an exciting step forward by announcing a significant strategic licensing partnership with Bang & Olufsen. This collaboration aims to infuse ‘Audio by Bang & Olufsen’ into RayNeo’s upcoming AR glasses, offering users a truly immersive...
Continue Reading
Understanding AI's Impact on Energy by Schneider Electric
AI and Energy Management Insights from Schneider Electric Schneider Electric, a leader in digital energy management and automation, has recently unveiled two integral research reports shedding light on the intersection of artificial intelligence (AI) and energy consumption. These comprehensive studies address pressing concerns regarding the sustainability of energy usage...
Continue Reading
Oil Prices Maintain Stability Amid Ceasefire Discussions and OPEC+ Meeting
Current Trends in Oil Prices In recent trading, oil prices appear to have steadied, reflecting a moment of cautious optimism among market participants. With a ceasefire deal between Israel and Hezbollah having been approved, traders are weighing what this might mean for global oil supplies and prices. The anticipated decisions at the upcoming OPEC+ meeting also play a...
Continue Reading